PLK4 and colorectal cancer: Data from another independent cohort of colorectal cancer patients of all TNM stages61 show a significant reduction in FAM46C/Plk4 ratio in primary tumor (T) vs. NM (Fig. 6e), and further depletion of FAM46C with clinical stage progression, as apparent in our own initial patient cohort (Fig. 6f).